ALMIB 📈 Amoeba SA - Overview
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0011051598
ALMIB: Biocides, Pesticides, Fungicides, Bactericides, Disinfectants, Microbiocides
Amoéba S.A. develops biological biocides for the prevention of microbiological risk for water, crop protection and health sectors. It develops applications using amoeba Willaertia magna C2c Maky. The company was incorporated in 2010 and is based in Chassieu, France. Web URL: https://amoeba-nature.com
Additional Sources for ALMIB Stock
ALMIB Stock Overview
| Market Cap in USD | 43m |
| Sector | Basic Materials |
| Industry | Agricultural Inputs |
| GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
| IPO / Inception |
ALMIB Stock Ratings
| Growth 5y | 11.1% |
| Fundamental | -15.3% |
| Dividend | - |
| Rel. Strength Industry | 97964 |
| Analysts | - |
| Fair Price Momentum | 0.96 EUR |
| Fair Price DCF | - |
ALMIB Dividends
No Dividends PaidALMIB Growth Ratios
| Growth Correlation 3m | 96.1% |
| Growth Correlation 12m | 82.5% |
| Growth Correlation 5y | -78% |
| CAGR 5y | 13.46% |
| CAGR/Mean DD 5y | 0.20 |
| Sharpe Ratio 12m | 1.38 |
| Alpha | 113.82 |
| Beta | 0.62 |
| Volatility | 96.15% |
| Current Volume | 327.9k |
| Average Volume 20d | 423.7k |
What is the price of ALMIB stocks?
As of December 22, 2024, the stock is trading at EUR 0.88 with a total of 327,918 shares traded.
Over the past week, the price has changed by -7.84%, over one month by +27.54%, over three months by +78.03% and over the past year by +148.02%.
As of December 22, 2024, the stock is trading at EUR 0.88 with a total of 327,918 shares traded.
Over the past week, the price has changed by -7.84%, over one month by +27.54%, over three months by +78.03% and over the past year by +148.02%.
Is Amoeba SA a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Amoeba SA is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -15.34 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALMIB as of December 2024 is 0.96. This means that ALMIB is currently overvalued and has a potential downside of 9.09%.
Neither. Based on ValueRay Fundamental Analyses, Amoeba SA is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -15.34 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALMIB as of December 2024 is 0.96. This means that ALMIB is currently overvalued and has a potential downside of 9.09%.
Is ALMIB a buy, sell or hold?
Amoeba SA has no consensus analysts rating.
Amoeba SA has no consensus analysts rating.
What are the forecast for ALMIB stock price target?
According to ValueRays Forecast Model, ALMIB Amoeba SA will be worth about 1.1 in December 2025. The stock is currently trading at 0.88. This means that the stock has a potential upside of +19.32%.
According to ValueRays Forecast Model, ALMIB Amoeba SA will be worth about 1.1 in December 2025. The stock is currently trading at 0.88. This means that the stock has a potential upside of +19.32%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 0.8 | -9.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 1.1 | 19.3% |